Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ONCY News

Recent news which mentions ONCY News

Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer
Tickers ONC ONCY
Tags ONCY News Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data
Tickers ONC ONCY
Tags Featured News ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep’s Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer
Tickers ONC ONCY
Tags Featured News ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Tickers ONC ONCY
Tags Featured News ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth
Tickers BLRX CADL IMRX ONC
Tags ONCY News Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Cancer Immunotherapy Stocks – Tapping into Immune Systems for Next Generation Treatments
Tickers ONC ONCY
Tags Featured News ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024
Tickers ONC ONCY
Tags ONCY News Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Announces the Anal Cancer Cohort of the GOBLET Phase 1/2 Study of Pelareorep and Atezolizumab Has Met the Success Criteria for Efficacy
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Achieves Success Criteria for Efficacy in the Third-Line Colorectal Cancer Cohort of the GOBLET Study
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023
Tickers ONC ONCY
Tags ONCY News Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech’s® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Announces Updated Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial that Show Pelareorep Driving Robust Increases in Progression-Free Survival and Confirmed Ov
Tickers ONC ONCY
Tags Featured News ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial Demonstrating Pelareorep Drives ≥50% Improvements in ORR and mPFS in an ASCO Annual Meetin
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Reports First Quarter 2023 Financial Results and Operational Highlights
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech’s® Chinese Development Partner Adlai Nortye Presents Interim Clinical Data Further Demonstrating the Anti-Cancer Activity of Pelareorep-Paclitaxel Combination Therapy in HR+/HER2- M
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Receives FDA Fast Track Designation for the Treatment of Advanced/Metastatic Pancreatic Cancer
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study’s Pancreatic Cancer Cohort
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Reports Interim Results from Phase 1/2 GOBLET Study Showing a 70% Objective Response Rate in Pancreatic Cancer at the SITC Annual Meeting
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 37th Annual Meeting
Tickers ONC ONCY
Tags ONCY News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.